CSF2 and COVID-19: Concerns that GM-CSF itself may contribute to hyperinflammation or cytokine storm in COVID-19 motivated trials of neutralizing antibodies to GM-CSF.42 Anti-GM-CSF antibodies have not shown unequivocal benefit.